HealthCor Partners II, L.P.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 11

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 0

Underlying: Common Stock · 96,068 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.

F7 · price: Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.

F7 · derivative.exercise_date: Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.

F7 · derivative.expiration_date: Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 10

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 0

Underlying: Common Stock · 452,528 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · shares: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · price: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · derivative.exercise_date: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · derivative.expiration_date: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 9

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 0

Underlying: Common Stock · 1,337,337 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · shares: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · price: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · derivative.exercise_date: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · derivative.expiration_date: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 8

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 0

Underlying: Common Stock · 1,099,378 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F5 · shares: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F5 · price: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F5 · derivative.exercise_date: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F5 · derivative.expiration_date: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 7

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthCor Partners Fund II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 208,604 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · shares: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · derivative.exercise_date: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · derivative.expiration_date: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F4 · ownership.nature: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 6

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 0

Underlying: Common Stock · 1,630,231 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · shares: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · derivative.exercise_date: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · derivative.expiration_date: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 5

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthCor Partners Fund II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 624,471 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · shares: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · derivative.exercise_date: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · derivative.expiration_date: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F4 · ownership.nature: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · derivative · entry 4

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthCor Partners Fund, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,248,939 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · shares: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · derivative.exercise_date: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F1 · derivative.expiration_date: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F2 · ownership.nature: HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · nonDerivative · entry 3

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HCPCIV 1, LLC

Disclosed balance after: 4,615,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F5 · price: Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F6 · price: Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F7 · price: Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.

F8 · ownership.nature: HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · nonDerivative · entry 2

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthCor Partners Fund II, L.P.

Disclosed balance after: 833,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F3 · price: Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F4 · ownership.nature: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0001062993-25-014851 · form4.xml · nonDerivative · entry 1

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

HealthCor Partners Fund LP · CIK 0001408660 · 10% owner

HealthCor Partners LP · CIK 0001519456 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HCPCIV 1, LLC · CIK 0002083103 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HealthCor Partners Fund, L.P.

Disclosed balance after: 1,248,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.

F2 · ownership.nature: HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein

F9 · ownership.nature: HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

SEC source: 0000908662-19-000232 · edgar.xml · nonDerivative · entry 3

HealthCor Management, L.P. · CIK 0001343781 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · kind: Disposed of pursuant to merger agreement by and among Issuer, Siemens Medical Solutions USA, Inc., and Corpus Merger, Inc., for a cash payment of the per share price noted.

F5 · ownership.nature: HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by Hybrid Fund may be deemed to be beneficially owned by HealthCor Hybrid Offshore GP, LLC ("Offshore GP"), its general partner, and by HealthCor Group, LLC ("Group"), the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of shares held by Hybrid Fund except to the extent of any pecuniary interest therein.

SEC source: 0000908662-19-000232 · edgar.xml · nonDerivative · entry 2

HealthCor Management, L.P. · CIK 0001343781 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · kind: Disposed of pursuant to merger agreement by and among Issuer, Siemens Medical Solutions USA, Inc., and Corpus Merger, Inc., for a cash payment of the per share price noted.

F3 · ownership.nature: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.

F4 · ownership.nature: HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.

SEC source: 0000908662-19-000232 · edgar.xml · nonDerivative · entry 1

HealthCor Management, L.P. · CIK 0001343781 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · kind: Disposed of pursuant to merger agreement by and among Issuer, Siemens Medical Solutions USA, Inc., and Corpus Merger, Inc., for a cash payment of the per share price noted.

F2 · ownership.nature: HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein.

F4 · ownership.nature: HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.

SEC source: 0000908662-18-000165 · edgar.xml · derivative · entry 2

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners Management GP, LLC · CIK 0001519463 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Lightcap Jeffrey C · CIK 0001519465 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,200

Underlying: Common Stock · 136,580 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Automatic conversion of 20,487 shares of Series C Preferred Stock into shares of Common Stock at a conversion ratio of 1:6.6667.

F5 · price: Issued as merger consideration.

F4 · derivative.expiration_date: N/A

F3 · ownership.direct: HealthCor Partners Fund II, L.P. ("HCPII Fund") is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.

SEC source: 0000908662-18-000165 · edgar.xml · nonDerivative · entry 1

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners Management LP · CIK 0001519462 · 10% owner

HealthCor Partners Management GP, LLC · CIK 0001519463 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Lightcap Jeffrey C · CIK 0001519465 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Share amounts and ratios reflect the 15-for-1 reverse stock split effected June 4, 2018.

F2 · price: Automatic conversion of 20,487 shares of Series C Preferred Stock into shares of Common Stock at a conversion ratio of 1:6.6667.

F3 · ownership.direct: HealthCor Partners Fund II, L.P. ("HCPII Fund") is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.

SEC source: 0000908662-17-000057 · edgar.xml · nonDerivative · entry 1

HealthCor Management, L.P. · CIK 0001343781 · 10% owner

HealthCor Partners Fund II, L.P. · CIK 0001538581 · 10% owner

HealthCor Partners II, L.P. · CIK 0001643094 · 10% owner

HealthCor Partners GP, LLC · CIK 0001519460 · 10% owner

Cohen Arthur Bruce · CIK 0001343780 · 10% owner

Healey Joseph Patrick · CIK 0001343779 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 15,409,537

F1 · shares: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.

F3 · shares: HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.

F1 · ownership.nature: HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.

F3 · ownership.nature: HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.